Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amikin 100mg/2ml solution for injection vials (Vianex S.A.) 5 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Multiparin 25,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) 10 vial 10 x 5ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium pamidronate 90mg/10ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 25,000units/1ml solution for injection ampoules (C P Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 100micrograms/1ml (1 in 10,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 75mg/10ml solution for injection ampoules (AstraZeneca) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 20mg/10ml solution for injection ampoules (AstraZeneca) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 0.2% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) 10 vial 10 x 5ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 0.5% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 3% solution for injection 5ml vials (STD Pharmaceutical Products Ltd) 10 vial 10 x 5ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fibro-Vein 1% solution for injection 2ml ampoules (STD Pharmaceutical Products Ltd) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Naropin 100mg/10ml solution for injection ampoules (AstraZeneca) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 40mg/1ml solution for injection ampoules (Alpharma Limited) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tobramycin 240mg/6ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nebcin 20mg/2ml solution for injection vials (King Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (Mayne Pharma Plc) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 15mg/2ml solution for injection ampoules (Unichem Plc) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
IntronA 60million units/1.2ml solution for injection multidose pens (Organon Pharma (UK) Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sublimaze 500micrograms/10ml solution for injection ampoules (Janssen-Cilag Ltd) 5 ampoule 5 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 500micrograms/10ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Aurum Pharmaceuticals Ltd) 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 1mg/10ml (1 in 10,000) solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 10,000units/10ml solution for injection ampoules (C P Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Multiparin 125,000units/5ml solution for injection vials (C P Pharmaceuticals Ltd) 10 vial 10 x 5ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Monoparin 25,000units/5ml solution for injection ampoules (C P Pharmaceuticals Ltd) 10 ampoule 10 x 5ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ergometrine 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carnitor 1g/5ml solution for injection ampoules (Shire Pharmaceuticals Ltd) 5 ampoule 5 x 5ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Proluton Depot 250mg/1ml solution for injection ampoules (Schering Health Care Ltd) 3 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anafranil 25mg/2ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
CosmoFer 100mg/2ml solution for injection ampoules (Pharmacosmos UK Ltd) 5 ampoule 5 x 2ml ampoules (product) |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Neostigmine 2.5mg/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 10% solution for injection 10ml ampoules (Unichem Plc) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Robinul-Neostigmine solution for injection 1ml ampoules (Goldshield Healthcare Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 3mg/10ml solution for injection pre-filled syringes (Unichem Plc) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline acid tartrate 5mg/5ml (1 in 1,000) solution for injection pre-filled syringes (Unichem Plc) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Limclair 1g/5ml solution for injection ampoules (B & S Durbin) 6 ampoule 6 x 5ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 1.25mg/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet naloxone 800micrograms/2ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 500micrograms/5ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 1mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Minijet atropine 3mg/30ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aramine 10mg/1ml solution for injection ampoules (Organon Pharma (UK) Ltd) 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (Martindale Pharmaceuticals Ltd) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lidocaine 100mg/5ml (2%) solution for injection pre-filled syringes (Unichem Plc) 1 pre-filled disposable injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Foscavir 6g/250ml solution for injection bottles (AstraZeneca) 1 bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Marcain 0.25% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tavanic 500mg/100ml solution for injection vials (Aventis Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml / Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Marcain 0.5% with Adrenaline 50micrograms/10ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cidomycin Intrathecal 5mg/1ml solution for injection ampoules (Aventis Pharma) 5 ampoule 5 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for infusion 10ml ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule 2 x 5 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium dihydrogen phosphate 13.6% (potassium 10mmol/10ml) solution for injection 10ml ampoules (Unichem Plc) 10 ampoule 10 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Retrovir I.V. for Infusion 20ml vials (GlaxoSmithKline) 5 vial 5 x 20ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacron 20mg/10ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule 5 x 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mivacron 10mg/5ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule 5 x 5ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylate 500mg/10ml solution for injection ampoules (GlaxoSmithKline) 1 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bretylate 100mg/2ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxotere 20mg/0.5ml solution for injection vials and diluent (Aventis Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pronestyl 1g/10ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxol 30mg/5ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxol 100mg/16.7ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Taxotere 80mg/2ml solution for injection vials and diluent (Aventis Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Isovorin 25mg/2.5ml solution for injection vials (Wyeth Laboratories) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 150mg/15ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 450mg/45ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
OxyNorm 10mg/1ml solution for injection ampoules (Napp Pharmaceuticals Ltd) 5 ampoule 5 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 150mg/15ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 450mg/45ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
OxyNorm 20mg/2ml solution for injection ampoules (Napp Pharmaceuticals Ltd) 5 ampoule 5 x 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium folinate 350mg/35ml solution for injection vials (C P Pharmaceuticals Ltd) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lederfolin 350mg/35ml solution for injection vials (Wyeth Laboratories) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Vistide 375mg/5ml solution for infusion vials (Gilead Sciences Ltd) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Vasoxine 20mg/1ml solution for injection ampoules (Glaxo Wellcome UK Ltd) 5 ampoule 5 x 1ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 50mg/5ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 50mg/5ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
HibTITER vaccine solution for injection 0.5ml vials (Wyeth Laboratories) 10 vial 10 x 0.5ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraplatin 600mg/60ml solution for injection vials (Bristol-Myers Squibb Pharmaceuticals Limited) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Carboplatin 600mg/60ml solution for injection vials (Mayne Pharma Plc) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Primacor 10mg/10ml solution for injection ampoules (Sanofi-Synthelabo Ltd) 10 ampoule 10 x 10ml ampolues |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Nitrocine 10mg/10ml solution for infusion ampoules (Forum Health Products Ltd) 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Aldurazyme 500units/5ml concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dicynene 250mg/2ml solution for injection ampoules (Sanofi-Synthelabo Ltd) 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Honvan 300mg/5ml solution for injection ampoules (ASTA Medica Ltd) 10 ampoule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|